Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
ReportID: 705152
|
Published Date: Oct-22
|
No. of Pages: 250
|
Categories: Life Sciences
|
Format : 
The A2Z Market Research report on “Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Report 2022 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029†offers strategic visions into the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2022 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Chimeric Antigen Receptor (CAR) T-Cell Therapy product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for Chimeric Antigen Receptor (CAR) T-Cell Therapy and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Chimeric Antigen Receptor (CAR) T-Cell Therapy market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Chimeric Antigen Receptor (CAR) T-Cell Therapy market are:
Celgene Corp.
Puretech Health
Cellectis
Gilead Sciences
Shire Pharmaceuticals Inc.
Juno Therapeutics Inc. (A Celgene Company)
Takeda Pharmaceuticals
Avacta Life Sciences Ltd.
Servier Laboratories
Bluebird Bio
Mustang Bio Inc.
Formula Pharmaceuticals Inc.
Transgene SA
iCell Gene Therapeutics
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Medimmune Llc/Astrazeneca
Novartis AG
Editas Medicine Inc.
Noile-Immune Biotech
Amgen
Celyad SA
Bellicum Phamaceuticals
Protheragen Inc.
F. Hoffman La Roche AG
Eureka Therapeutics Inc.
Market segmentation by Type:
Acute Lymphoblastic Leukemia (ALL), Advanced Lymphomas, Others
Market segmentation by Application:
Children, Adult
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for Chimeric Antigen Receptor (CAR) T-Cell Therapy and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Chimeric Antigen Receptor (CAR) T-Cell Therapy market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Chimeric Antigen Receptor (CAR) T-Cell Therapy market are:
Celgene Corp.
Puretech Health
Cellectis
Gilead Sciences
Shire Pharmaceuticals Inc.
Juno Therapeutics Inc. (A Celgene Company)
Takeda Pharmaceuticals
Avacta Life Sciences Ltd.
Servier Laboratories
Bluebird Bio
Mustang Bio Inc.
Formula Pharmaceuticals Inc.
Transgene SA
iCell Gene Therapeutics
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Medimmune Llc/Astrazeneca
Novartis AG
Editas Medicine Inc.
Noile-Immune Biotech
Amgen
Celyad SA
Bellicum Phamaceuticals
Protheragen Inc.
F. Hoffman La Roche AG
Eureka Therapeutics Inc.
Market segmentation by Type:
Acute Lymphoblastic Leukemia (ALL), Advanced Lymphomas, Others
Market segmentation by Application:
Children, Adult
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Type
1.2.1 Global Production Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Application
1.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Chimeric Antigen Receptor (CAR) T-Cell Therapy (2014-2029)
Chapter 2 Global Economic Impact on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competition by Manufacturers
3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Share by Manufacturers (2020 and 2022)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Situation and Trends
3.5.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Rate
3.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue (Value) by Region (2014-2022)
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production by Region (2014-2022)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Market Share by Region (2014-2022)
4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Regions (2014-2022)
5.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue (Value), Price Trend by Type
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Market Share by Type (2014-2022)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Type (2014-2022)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2014-2022)
6.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Growth by Type (2014-2022)
Chapter 7 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Application
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2014-2022)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Cost Analysis
8.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast (2022-2029)
12.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue Forecast (2022-2029)
12.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Forecast by Type (2022-2029)
12.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Forecast by Application (2022-2029)
12.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Price Forecast (2022-2029)
Chapter 13 Appendix
Chapter 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Type
1.2.1 Global Production Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Application
1.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Chimeric Antigen Receptor (CAR) T-Cell Therapy (2014-2029)
Chapter 2 Global Economic Impact on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competition by Manufacturers
3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Share by Manufacturers (2020 and 2022)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Situation and Trends
3.5.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Rate
3.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue (Value) by Region (2014-2022)
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production by Region (2014-2022)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Market Share by Region (2014-2022)
4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Regions (2014-2022)
5.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue (Value), Price Trend by Type
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Market Share by Type (2014-2022)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Type (2014-2022)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2014-2022)
6.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Growth by Type (2014-2022)
Chapter 7 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Application
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2014-2022)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Cost Analysis
8.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast (2022-2029)
12.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Revenue Forecast (2022-2029)
12.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Forecast by Type (2022-2029)
12.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Forecast by Application (2022-2029)
12.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Price Forecast (2022-2029)
Chapter 13 Appendix
Published On:Oct-22
Base Year:
Historical Data:
No of Pages:250
Price
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
